These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33831964)
21. Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. Biamonte F; Botta C; Mazzitelli M; Rotundo S; Trecarichi EM; Foti D; Torti C; Viglietto G; Torella D; Costanzo F J Transl Med; 2021 Feb; 19(1):79. PubMed ID: 33596963 [TBL] [Abstract][Full Text] [Related]
22. Hemostatic and liver function parameters as COVID-19 severity markers. Iqbal Q; Mudatsir M; Harapan H; Nurjannah N; Maulana T Narra J; 2024 Apr; 4(1):e178. PubMed ID: 38798852 [TBL] [Abstract][Full Text] [Related]
23. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019. Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545 [TBL] [Abstract][Full Text] [Related]
24. Platelet and Monocyte Microvesicles as Potential Biomarkers of COVID-19 Severity: A Cross-Sectional Analysis. Nunki N; Hernaningsih Y; Wardhani P; Herawati A; Mohd Yusoff N; Moses EJ; Semedi BP Ann Lab Med; 2024 Sep; 44(5):392-400. PubMed ID: 38469637 [TBL] [Abstract][Full Text] [Related]
25. Effects of batroxobin on the antithrombotic system in patients with cerebral venous thrombosis: Clues to mechanisms. Lan D; Jiao B; Song S; Wang M; Zhang X; Huang X; Guo Y; Ding Y; Ji X; Meng R CNS Neurosci Ther; 2024 Aug; 30(8):e14861. PubMed ID: 39097912 [TBL] [Abstract][Full Text] [Related]
26. Calculated plasma osmolality at hospital admission correlates well with eGFR and D-Dimer, a simple outcome predictor and guiding tool for management of severe COVID-19 patients. Ramesh J; Rajesh M; Varghese J; Reddy SLS Diabetes Metab Syndr; 2021; 15(5):102240. PubMed ID: 34403950 [TBL] [Abstract][Full Text] [Related]
27. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency. Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392 [TBL] [Abstract][Full Text] [Related]
28. Coronavirus-induced coagulopathy during the course of disease. Friedrich MS; Studt JD; Braun J; Spahn DR; Kaserer A PLoS One; 2020; 15(12):e0243409. PubMed ID: 33332362 [TBL] [Abstract][Full Text] [Related]
29. Elevated levels of D-dimer in patients with COVID-19: prognosis value. Oualim S; Abdeladim S; Ouarradi AE; Bensahi I; Hafid S; Naitlho A; Bouaiti E; Sabry M Pan Afr Med J; 2020; 35(Suppl 2):105. PubMed ID: 33282060 [TBL] [Abstract][Full Text] [Related]
30. Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use. Aydınyılmaz F; Aksakal E; Pamukcu HE; Aydemir S; Doğan R; Saraç İ; Aydın SŞ; Kalkan K; Gülcü O; Tanboğa İH Clin Appl Thromb Hemost; 2021; 27():10760296211048808. PubMed ID: 34713729 [TBL] [Abstract][Full Text] [Related]
31. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334 [TBL] [Abstract][Full Text] [Related]
32. Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19. Hoogenboom WS; Lu JQ; Musheyev B; Borg L; Janowicz R; Pamlayne S; Hou W; Duong TQ PLoS One; 2022; 17(1):e0262811. PubMed ID: 35045130 [TBL] [Abstract][Full Text] [Related]
33. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19. Mei H; Luo L; Hu Y J Hematol Oncol; 2020 Dec; 13(1):161. PubMed ID: 33261634 [TBL] [Abstract][Full Text] [Related]
34. Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study. Ishii K; Kinoshita T; Kiridume K; Watanabe A; Yamakawa K; Nakao S; Fujimi S; Matsuoka T Scand J Trauma Resusc Emerg Med; 2019 Feb; 27(1):25. PubMed ID: 30819212 [TBL] [Abstract][Full Text] [Related]
35. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. Goldenberg NA; Knapp-Clevenger R; Manco-Johnson MJ; N Engl J Med; 2004 Sep; 351(11):1081-8. PubMed ID: 15356305 [TBL] [Abstract][Full Text] [Related]
36. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G Thromb Haemost; 2011 May; 105(5):837-45. PubMed ID: 21359409 [TBL] [Abstract][Full Text] [Related]
37. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019]. Xu Y; Qian Y; Gu Q; Tang J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347 [TBL] [Abstract][Full Text] [Related]
39. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation. Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031 [TBL] [Abstract][Full Text] [Related]
40. The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals. Nkambule BB; Davison GM; Ipp H Int J Lab Hematol; 2015 Aug; 37(4):450-8. PubMed ID: 25401263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]